Sort
50,496 grants matching “lung cancer”
Molecular Recognition during pre-mRNA Splicing
$388,819Clara L Kielkopf · University Of Rochester · R01 · FY2015 · GM
Computational and Experimental Modeling of Alternative Polyadenylation
$388,808Wei Li · University Of California-Irvine · R01 · FY2022 · CA
Integrated pathway analysis of altered driver genes in adenoid cystic carcinoma
$388,800Patrick Kyongmin Ha · Johns Hopkins University · R01 · FY2013 · DE
Regulation of Death Receptor 5 folding and apoptotic signaling by AGR2
$388,757Brian K Law · University Of Florida · R21 · FY2020 · CA
Tumor-Homing Exosomes for Drug Delivery
$388,750Thomas Anchordoquy · University Of Colorado Denver · R01 · FY2016 · EB
Pathogen-induced immune and stress responses mediated by bZIP transcription factors
$388,750Ransome Van Der Hoeven · University Of Iowa · R01 · FY2024 · AI
In Vivo Regulation of Factor IXa by Protein S in Hemophilia and Systemic Hypercoagulability
$388,750John Patrick Sheehan · University Of Wisconsin-Madison · R01 · FY2023 · HL
Senescent CAFs in Breast Cancer Progression
$388,750Sheila A Stewart · Washington University · R56 · FY2024 · AG
Identification of novel targets for the treatment of chemotherapy-induced painful peripheral neuropathy
$388,750Ohannes Kevork Melemedjian · University Of Maryland Baltimore · R01 · FY2024 · CA
In Vivo Regulation of Factor IXa by Protein S in Hemophilia and Systemic Hypercoagulability
$388,750John Patrick Sheehan · University Of Wisconsin-Madison · R01 · FY2022 · HL
Pathogen-induced immune and stress responses mediated by bZIP transcription factors
$388,750Ransome Van Der Hoeven · University Of Iowa · R01 · FY2025 · AI
Project 2
$388,732David A Barbie · Dana-Farber Cancer Inst · P50 · FY2024 · CA
Community Outreach and Engagement
$388,710Ken A. Resnicow · University Of Michigan At Ann Arbor · P30 · FY2018 · CA
Statistical Methods for Identification and Evaluation of Predictive Biomarkers in Cancer
$388,673Li Chen · University Of Kentucky · R21 · FY2024 · CA
LOW DOSE SPIRAL CT SCREENING FOR LUNG CANCER
$388,656Mayo Clinic Coll Of Medicine, Rochester · R01 · FY2001 · CA
Tumor-selective use of PARP inhibitors against NQO1+ nonsmall cell lung cancer
$388,637David A Boothman · Indiana University Indianapolis · R01 · FY2017 · CA
Target MKP-1 for Therapy-Resistant Breast Cancer Stem Cells
$388,601Jian Jian Li · University Of California At Davis · R01 · FY2012 · CA
Development of a universal tagging method for genome wide ChIP analyses
$388,575Zhenghe Wang · Case Western Reserve University · R01 · FY2010 · HG
Germline and Somatic Genetic Changes in Pulmonary Arterial Hypertension
$388,575Micheala A Aldred · Cleveland Clinic Lerner Com-Cwru · R01 · FY2012 · HL
Combinatorial Treatment Strategies to Counteract EGFR Resistance
$388,548Liuqing Yang · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA
Role of autophagy in tumor cell death
$388,542Andrew M Thorburn · University Of Colorado Denver · R01 · FY2015 · CA
Revisiting Prior Cancer as an Exclusion Criterion for Cancer Clinical Trials
$388,513Sandi Leigh Pruitt · Ut Southwestern Medical Center · R01 · FY2018 · CA
Preventive Interventions Leadership U01
$388,513Samir M Hanash · Fred Hutchinson Cancer Research Center · U01 · FY2012 · CA
Comprehensive Confocal Microscopy for Image Guided Biopsy
$388,442Guillermo J. Tearney · Massachusetts General Hospital · R21 · FY2010 · CA
Optimization and Validation of Single-Molecule Kinetic Fingerprinting Technology for Rapid, Ultra-Specific Detection of Cancer Mutations
$388,440Muneesh Tewari · University Of Michigan At Ann Arbor · R33 · FY2020 · CA